Land: Australien
Sprog: engelsk
Kilde: Department of Health (Therapeutic Goods Administration)
latanoprost, Quantity: 0.05 mg/mL; timolol maleate, Quantity: 6.83 mg/mL (Equivalent: timolol, Qty 5 mg/mL)
Arrotex Pharmaceuticals Pty Ltd
Latanoprost,Timolol maleate
Eye Drops, solution
Excipient Ingredients: sodium hydroxide; dibasic sodium phosphate dodecahydrate; purified water; benzalkonium chloride; hydrochloric acid; monobasic sodium phosphate dihydrate; sodium chloride
Ophthalmic
3 x 2.5 mL, 1 x 2.5 mL
(S4) Prescription Only Medicine
Reduction of elevated intraocular pressure in patients with open-angle glaucoma and ocular hypertension who are insufficiently responsive to beta-blockers, prostaglandins or other intraocular pressure lowering medications. Latanoprost/timolol (50 microgram/mL/5 mg/mL) eye drops should not be used to initiate therapy.
Visual Identification: Clear, colourless liquid.; Container Type: Bottle; Container Material: LDPE; Container Life Time: 21 Months; Container Temperature: Store at 2 to 8 degrees Celsius
Licence status A
2017-03-20